Related Experiment Video

Updated: Jun 21, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Programming the immunological properties of mRNA vaccines for cancer

Annette Wu1, Seong Dong Jeong2,3, Benjamin R Schrank1

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Nature Reviews. Immunology
|June 19, 2026
PubMed

Insights

Messenger RNA (mRNA) cancer vaccines offer a programmable approach to harness immune responses. This framework optimizes vaccine design to balance immune activation, enhancing efficacy while minimizing toxicity and T cell exhaustion for durable anti-tumor immunity.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Messenger RNA (mRNA) vaccines represent a novel platform for cancer immunotherapy, demonstrating potential in clinical trials.
  • Inducing robust and specific immune responses is critical for effective cancer vaccines.

Purpose of the Study:

  • To propose an immunological framework for optimizing mRNA cancer vaccine efficacy.
  • To reconcile key axes influencing vaccine outcomes: adjuvanticity, antigen response, immune memory, and trained immunity.

Main Methods:

  • Development of a conceptual framework integrating four critical immunological axes.
  • Analysis of mechanistic and translational data within the proposed framework.
  • Identification of design principles for tuning mRNA vaccine properties.

Main Results:

  • mRNA vaccines can be programmed via nucleoside chemistry, delivery, and dosing to modulate immune responses.
  • Manipulation of antigen identity, costimulation, cytokines, and innate stimulation is key.
  • The framework guides optimization towards durable, tumor-specific immunity.

Conclusions:

  • An optimized window of immune activation is achievable with careful vaccine design.
  • This approach aims to maximize anti-tumor efficacy while mitigating T cell exhaustion, tolerance, and toxicity.
  • The framework provides principles for advancing mRNA cancer vaccine development.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes08:27

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...